Open Nav

SignalRx Pharmaceuticals, Inc.

  • Guillermo Morales, SignalRx Pharmaceuticals, Inc.

Partner to accelerate assets development to clinical trials

  • Date:Wednesday, October 17
  • Time:9:45 AM - 10:00 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:SignalRx Pharmaceuticals, Inc. is a clinical-stage company developing novel small-molecules therapeutics via in-silico design to simultaneously inhibit multiple key orthogonal and synergistic oncotargets for cancer treatment. Our mission is to enable new levels of sophisticated combination treatments for cancer patients to help improve their quality and length of life.
  • Company
  • Company HQ City:San Diego
  • Company HQ Country:United States
  • Company HQ State:California                  
  • Year Founded:2012
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development :SF2523
  • Development Phase of Primary Product:Pre-Clinical
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :3
  • Total Amount Raised to Date, In All Rounds:$2.97M
Guillermo Morales
SignalRx Pharmaceuticals, Inc.